Hematologic Markers Better Predict Left Ventricular Assist Device Thrombosis than Echocardiographic or Pump Parameters

Abstract

Background Left ventricular assist device (LVAD) thrombosis is a life-threatening complication that remains a major clinical problem. Consensus diagnostic criteria do not exist. We investigated whether hematologic, echocardiographic, or pump parameters reliably change during LVAD thrombosis.

Methods A retrospective analysis of 20 consecutive cases of continuous-flow LVAD thrombosis (Thoratec HeartMate II n = 16, HeartWare HVAD n = 4) was performed. Hematologic markers (lactate dehydrogenase, plasma-free hemoglobin, hemoglobin, creatinine), echocardiographic parameters (left ventricular end-systolic and end-diastolic diameter, mitral regurgitation, aortic insufficiency, inflow-cannula velocity), and pump characteristics (speed, power, estimated flow, pulsatility index) were analyzed with one-way repeated measures ANOVA with Tukey post-test or paired Student t-tests.

Results Lactate dehydrogenase and plasma-free hemoglobin were significantly (p < 0.05) elevated at admission for LVAD thrombosis. Hemoglobin and creatinine were not significantly different at admission but changed significantly after admission. Left ventricular end-systolic and end-diastolic diameter, mitral regurgitation, aortic insufficiency, inflow-cannula velocity, LVAD speed, power consumption, estimated flow, and pulsatility index were not significantly different at admission for LVAD thrombosis.

Conclusion Hematological markers of hemolysis, but not echocardiographic or pump parameters, reliably changed during LVAD thrombosis. Markers of hemolysis are the best early predictors of LVAD thrombosis.

Keywords

heart failure - left ventricular assist device - mechanical circulatory support - thrombosis

• References

• 1 Bartoli CR, Dowling RD. The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies. Cardiol Clin 2011; 29 (4) 559-582
• 2 Kirklin JK, Naftel DC, Kormos RL , et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 2013; 32 (2) 141-156
• 3 Starling RC, Moazami N, Silvestry SC , et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014; 370 (1) 33-40
• 4 Najjar SS, Slaughter MS, Pagani FD , et al; HVAD Bridge to Transplant ADVANCE Trial Investigators. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2014; 33 (1) 23-34
• 5 Eckman PM, John R. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 2012; 125 (24) 3038-3047
• 6 Bartoli CR, Ailawadi G, Kern JA. Diagnosis, nonsurgical management, and prevention of LVAD thrombosis. J Card Surg 2014; 29 (1) 83-94
• 7 Slaughter MS, Rogers JG, Milano CA , et al; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361 (23) 2241-2251
• 8 Park SJ, Milano CA, Tatooles AJ , et al; HeartMate II Clinical Investigators. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012; 5 (2) 241-248
• 9 Aaronson KD, Slaughter MS, Miller LW , et al; HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012; 125 (25) 3191-3200
• 10 Goldstein DJ, Zucker M, Arroyo L , et al. Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J Am Coll Cardiol 2005; 45 (6) 962-963
• 11 Goldstein DJ, John R, Salerno C , et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant 2013; 32 (7) 667-670
• 12 Slaughter MS, Pagani FD, Rogers JG , et al; HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 29 (4, Suppl): S1-S39
• 13 Horton SC, Khodaverdian R, Chatelain P , et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol 2005; 45 (9) 1435-1440
• 14 Chumnanvej S, Wood MJ, MacGillivray TE, Melo MF. Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg 2007; 105 (3) 583-601
• 15 Estep JD, Stainback RF, Little SH, Torre G, Zoghbi WA. The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. JACC Cardiovasc Imaging 2010; 3 (10) 1049-1064
• 16 Catena E, Milazzo F. Echocardiography and cardiac assist devices. Minerva Cardioangiol 2007; 55 (2) 247-265
• 17 Catena E, Milazzo F, Montorsi E , et al. Left ventricular support by axial flow pump: the echocardiographic approach to device malfunction. J Am Soc Echocardiogr 2005; 18 (12) 1422
• 18 Scalia GM, McCarthy PM, Savage RM, Smedira NG, Thomas JD. Clinical utility of echocardiography in the management of implantable ventricular assist devices. J Am Soc Echocardiogr 2000; 13 (8) 754-763
• 19 Paluszkiewicz L, Gürsoy D, Spiliopoulos S , et al. HeartMate II ventricular assist device thrombosis-an echocardiographic approach to diagnosis: can Doppler evaluation of flow be useful?. J Am Soc Echocardiogr 2011; 24 (3) e1-e4
• 20 Aissaoui N, Paluszkiewicz L, Koertke HH, Morshuis M, Gummert J. Echocardiography can be more sensitive than thoracic computed tomography in detecting a thrombus in the inflow cannula of a continuous left ventricular assist device. Echocardiography 2011; 28 (10) E215-E216
• 21 Sims DB, Takayama H, Uriel N, Gillam LD, Naka Y, Jorde UP. Ventricular assist device-associated thrombus. Circulation 2011; 124 (7) e197-e198
• 22 Uriel N, Morrison KA, Garan AR , et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. J Am Coll Cardiol 2012; 60 (18) 1764-1775
• 23 Ferns J, Dowling R, Bhat G. Evaluation of a patient with left ventricular assist device dysfunction. ASAIO J 2001; 47 (6) 696-698
• 24 Kiernan MS, Pham DT, DeNofrio D, Kapur NK. Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. J Thorac Cardiovasc Surg 2011; 142 (3) 712-714
• 25 Raman SV, Sahu A, Merchant AZ, Louis IV LB, Firstenberg MS, Sun B. Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management. J Heart Lung Transplant 2010; 29 (1) 79-85
• 26 Rothenburger M, Wilhelm MJ, Hammel D , et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 2002; 106 (12, Suppl 1): I189-I192